Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategies. - Jielin Xu; Kelly Regan-Fendt; Siyuan Deng; William E. Carson III; Philip R. O. Payne; Fuhai Li 001 (PSB, 2018)

Comprehensively modeling heterogeneous symptom progression for Parkinson's disease subtyping. - Chang Su 002; Yu Hou; Jielin Xu; Matthew Brendel; Jacqueline R. M. A. Maasch; Zilong Bai; Yingying Zhu 003; Claire Henchcliffe; Feixiong Cheng; Fei Wang 001 (AMIA, 2022)

Design of Virtual Reality Scenes on Horticultural Therapy Treatment. - Jielin Xu; Dan Liao; Xiaojun Peng; Guodong Liang; Yafei Li; Xiangqing Zheng (HCI (11), 2022)

Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer's disease. - Chirag Gupta; Jielin Xu; Ting Jin; Saniya Khullar; Xiaoyu Liu; Sayali Alatkar; Feixiong Cheng; Daifeng Wang (PLoS Comput. Biol., 2022)

Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data. - Chang Su 002; Yu Hou; Jielin Xu; Zhenxing Xu; Manqi Zhou; Alison Ke; Haoyang Li 001; Jie Xu 012; Matthew Brendel; Jacqueline R. M. A. Maasch; Zilong Bai; Haotan Zhang; et al. (npj Digit. Medicine, 2024)